The United Kingdom founded a new £16.5 million (USD $30 million) stem cell center in Cambridge this week with a commitment to fundamental research on both human embryonic and adult stem cells as a precursor to studying therapeutic applications.
The center's director, Roger Pedersen, professor of regenerative medicine at Cambridge University, dismissed calls to focus purely on adult and postnatal stem cells taken from the umbilical cord. "More than half of the research will be on embryonic stem cells," he told
The United Kingdom has recently passed several milestones in...